United States Antimony (UAMY) awards RSUs and stock options to COO

Rhea-AI Filing Summary

United States Antimony Corp. reported new equity awards to officer Melissa Pagen, President & COO, BRZ, dated January 15, 2026. She received 40,603 restricted stock units (RSUs), which will vest in three equal installments of 13,535 shares on January 15, 2027, January 18, 2028, and January 19, 2029, subject to continued service. She was also granted stock options covering 61,627 shares of common stock at an exercise price of $8.29 per share. The options vest upon achievement of specified performance measures at any time during their 10‑year term, contingent on her continued service.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Pagen Melissa

(Last) (First) (Middle)

4438 W. LOVERS LANE, UNIT 100

(Street)

DALLAS TX 75209

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
UNITED STATES ANTIMONY CORP [ UAMY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President & COO, BRZ

3. Date of Earliest Transaction (Month/Day/Year)
01/15/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Common Stock(1)	$0.00	01/15/2026		A		40,603(1)		(1)	(1)	Common Stock	40,603	(1)	0(1)	D
Stock Option(2)	$8.29	01/15/2026		A		61,627(2)		(2)	(2)	Common Stock	61,627	(2)	0(2)	D

Explanation of Responses:

1. Represents shares of Common Stock underlying a time-based vesting restricted stock unit ("RSU") award granted on January 15, 2026, under the Issuer's Amended & Restated 2023 Equity Incentive Plan. One-third, or 13,535 shares of the 40,603 total number of shares of the RSU award will vest on January 15, 2027, and an additional one-third of the total number of shares will vest on January 18, 2028 and January 19, 2029, subject to the Reporting Person's continued service through each vesting date.

2. Represents shares of Common Stock underlying a stock option award granted on January 15, 2026 under the Issuer's Amended & Restated 2023 Equity Incentive Plan. The stock option will vest upon meeting any of the performance measures specified in the grant at any time during the 10-year term of the award, subject to the Reporting Person's continued service through any vesting date.

	/s/ Melissa M. Pagen	02/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did UAMY disclose for Melissa Pagen?

United States Antimony Corp. disclosed equity awards to officer Melissa Pagen. She received 40,603 restricted stock units and stock options for 61,627 shares, both granted on January 15, 2026, as part of the company’s Amended & Restated 2023 Equity Incentive Plan.

How many RSUs did UAMY grant to Melissa Pagen and how do they vest?

Melissa Pagen received 40,603 time-based restricted stock units. One-third, or 13,535 RSUs, will vest on January 15, 2027, with additional one-third installments vesting on January 18, 2028, and January 19, 2029, assuming she continues serving through each vesting date.

What stock options did UAMY grant to Melissa Pagen on January 15, 2026?

She was granted stock options on January 15, 2026 covering 61,627 shares of United States Antimony common stock. These options were issued under the Amended & Restated 2023 Equity Incentive Plan and carry an exercise price of $8.29 per share, according to the reported data.

What are the vesting conditions for Melissa Pagen’s UAMY stock options?

The stock options vest upon meeting specified performance measures in the grant at any time during the 10-year award term. Vesting also requires Melissa Pagen’s continued service with United States Antimony through any date on which the performance conditions are satisfied.

Is the UAMY Form 4 a stock sale or a grant to Melissa Pagen?

The Form 4 reflects equity grants to Melissa Pagen, not an open-market stock sale. It reports an award of 40,603 restricted stock units and performance-based options for 61,627 shares, both issued under United States Antimony’s Amended & Restated 2023 Equity Incentive Plan.

Under which plan were Melissa Pagen’s UAMY RSUs and options granted?

Both the restricted stock units and stock options were granted under United States Antimony’s Amended & Restated 2023 Equity Incentive Plan. The filing ties each award to this plan, indicating they are part of the company’s structured equity compensation program for executives.